Skip to main content
Premium Trial:

Request an Annual Quote

Zyomyx Pockets $27M in Series E Round

NEW YORK, July 30 - Zyomyx said today it has pocketed $27 million in a Series E round of private-equity financing.

Investors included existing group Credit Suisse First Boston Private Equity and newcomers Lilly BioVentures and GE Life Science and Technology Finance.

Zyomyx said the cash will go to help ramp up and launch its human cytokine protein-profiling biochip, due in early 2003.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.